News
UK government to reclassify pregabalin and gabapentin after rise in deaths
BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j4441 (Published 25 September 2017) Cite this as: BMJ 2017;358:j4441- Gareth Iacobucci
- The BMJ
The UK government is to reclassify the prescription drug pregabalin as a class C controlled substance, after experts issued safety warnings following an increase in deaths linked to its use.
A Home Office consultation, which also proposes reclassifying gabapentin, has been launched in response to growing pressure for the drug to be reclassified to tackle misuse and addiction.
Last year the Advisory Council on the Misuse of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £157 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.